It commonly takes months before clinicians identify effective antidepressant treatment for their depressed patients. During this period a person's ability to work and function socially is severely impaired. i-spero® helps sufferers get better faster and return to work sooner.
i-spero® will help to get the patient on the right treatment at the right time, and allow both the patient and care providers to monitor symptoms through to recovery. This will improve primary care resilience whilst avoiding unnecessary referrals to secondary care and specialist providers associated with a lack of primary care capacity. This benefits the whole health system economy.
i-spero® is led by an experienced management team with proven expertise in product development, clinical research, digital technology and successful entrepreneurship.
i-spero® is the result of years of clinical practice and research by some of the leading minds in psychopharmacology and psychiatry. Many now comprise our advisory board where their passion drives the ongoing development of our products.
Through collaboration with world renowned academic advisors and physicians, we have created a highly experienced team that is well positioned to deliver and maximise the impact of this project.
If you are a primary care provider, or are responsible for the purchasing/commissioning of primary care or specialist mental health services we would welcome a discussion.